000 01109 a2200289 4500
005 20250517085850.0
264 0 _c20160421
008 201604s 0 0 rus d
022 _a0040-3660
024 7 _a10.17116/terarkh20158712101-106
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStatsenko, M E
245 0 0 _a[Unsolved problems of cytoprotective therapy in patients with coronary heart disease].
_h[electronic resource]
260 _bTerapevticheskii arkhiv
_c2015
300 _a101-106 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aCardiotonic Agents
_xadministration & dosage
650 0 4 _aCardiovascular Agents
_xadministration & dosage
650 0 4 _aCoronary Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMethylhydrazines
_xadministration & dosage
650 0 4 _aTrimetazidine
_xadministration & dosage
700 1 _aTurkina, S V
700 1 _aErmolenko, A A
773 0 _tTerapevticheskii arkhiv
_gvol. 87
_gno. 12
_gp. 101-106
856 4 0 _uhttps://doi.org/10.17116/terarkh20158712101-106
_zAvailable from publisher's website
999 _c25871617
_d25871617